Post MHRA nod, Pfizer-BioNTech expect US FDA, EU EMA decisions this month too First doses expected to arrive in the UK in days, companies had agreed to supply 40 million doses to the UK with delivery in 2020…
Pfizer-BioNTech COVID vaccine candidate succeeds in first interim analysis from phase 3 trial The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90 per…
Promising study results raise hopes for coronavirus vaccines This proves that science is moving forward very quickly, which is a good sign
Pfizer, BioNTech’s COVID-19 vaccine expected to be ready for approval by year end Several hundred million doses could be produced even before the approval
BioNTech and Pfizer’s COVID-19 vaccine shows potential in human trial The drug is one of 17 being tested on humans in a frantic global race to find a vaccine A COVID-19 vaccine developed by German…
US FDA comes out with guidance for COVID-19 vaccine approval More than 100 vaccines are being tested worldwide against the virus The US Food and Drug Administration released…
Serum Institute of India develops affordable pneumonia vaccine This will enable countries and treatment providers to procure more affordable versions of the vaccine, which has been out of reach…